Scientists discuss recent advances in understanding how T follicular helper cell crosstalk with B cells and CD8+ T cells in secondary and tertiary lymphoid structures enhances antitumor immunity, but may also exacerbate immune-related adverse events related to cancer immunotherapy.
[Trends in Cancer]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
